NanoVibronix Ownership
| NAOV Stock | USD 6.25 0.35 5.93% |
Shares in Circulation | First Issued 2012-09-30 | Previous Quarter 269.8 K | Current Value 484.6 K | Avarage Shares Outstanding 1.4 M | Quarterly Volatility 5 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
NanoVibronix | Build AI portfolio with NanoVibronix Stock |
NanoVibronix Stock Ownership Analysis
The company has price-to-book ratio of 0.12. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NanoVibronix recorded a loss per share of 172.7. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 12th of August 2025. NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York. Nanovibronix operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. To find out more about NanoVibronix contact Brian Murphy at 914 233 3004 or learn more at https://www.nanovibronix.com.NanoVibronix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as NanoVibronix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NanoVibronix backward and forwards among themselves. NanoVibronix's institutional investor refers to the entity that pools money to purchase NanoVibronix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 13.6 K | Ubs Group Ag | 2025-03-31 | 5.2 K | Citigroup Inc | 2025-06-30 | 2.5 K | Tower Research Capital Llc | 2025-03-31 | 1 K | Bank Of America Corp | 2025-03-31 | 7.0 | Vanguard Group Inc | 2025-03-31 | 0.0 | Geode Capital Management, Llc | 2025-03-31 | 0.0 | Armistice Capital, Llc | 2025-03-31 | 0.0 | Virtu Financial Llc | 2025-03-31 | 0.0 | Two Sigma Securities, Llc | 2025-03-31 | 0.0 | Citadel Advisors Llc | 2025-03-31 | 0.0 |
NanoVibronix Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NanoVibronix insiders, such as employees or executives, is commonly permitted as long as it does not rely on NanoVibronix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NanoVibronix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
NanoVibronix Outstanding Bonds
NanoVibronix issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NanoVibronix uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NanoVibronix bonds can be classified according to their maturity, which is the date when NanoVibronix has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
NanoVibronix Corporate Filings
10Q | 19th of August 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 14th of August 2025 Other Reports | ViewVerify | |
8K | 8th of August 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 25th of June 2025 Other Reports | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NanoVibronix Stock Analysis
When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.